RE:RE:It's holding pretty steady Walter. Waiting to buy cheaper LETS GO HEMOSTEMIX!!!!
Anyone know if they obtained the keys to the data yet or just confirmed that it wasnt corrupted? It might take a few months to analyze the data and write up a paper.
If this works the upside really is huge as a single use but also potentially for co-therapy for all the other stem-cell companies out there attempting to grow various cell lines.... they all need a vascular base and HEMO's got it!!!!! To hell with "pouches"!
The CEO compared Hem to MyoKardia...13b buyout. At first I though it was a foolish comparison but if you look at what MyoKardia has (drug for hypertrophic cardiomyopathy, just approved yesterday!), thats got nothin on the potential for HEMO's product!
Bristol paid $225/share for MyoKardia before Phaselll results!
im goin' boat shopping soon!!!!